![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() by Ed Adamczyk Washington DC (UPI) Mar 23, 2020
The hospital ship USNS Mercy will leave its home port of San Diego for Los Angeles on Monday, FEMA Administrator Peter Gaynor said. The ship, with 1,000 beds, is built to treat those wounded by war and trauma, and will not treat Southern California's COVID-19 cases. Its visit, expected to last one week, is instead meant to alleviate pressure on local hospitals as they deal with the pandemic. "The ship will serve as a referral hospital for non-COVID-19 patients currently admitted to shore-based hospitals and will provide a full spectrum of medical care to include critical and urgent care for adults," Gaynor said on Sunday. "This will allow local health professionals to focus on treating COVID-19 patients and for shore-based hospitals to use their Intensive Care Units and ventilators for those patients." The governors of both California and Washington requested hospital aid in the form of the USNS Mercy, but Gaynor said the projected need was five times greater in the Los Angeles area than in the Seattle area. The ship will depart Naval Base San Diego with over 800 Navy medical personnel and support staff from the Navy's Bureau of Medicine and Surgery, and at least 70 civilian support staff. It serves as a floating hospital -- referred to as a medical treatment facility, or MFT, with civil service mariners operating the ship, loading and unloading cargo and providing essential services. The USNS Mercy, and its sister ship USNS Comfort, support expeditionary warfare as their prime mission, and secondarily are involved in disaster relief and humanitarian operations. The USNS Mercy is a converted Navy supertanker, and was delivered to the Navy's Military Medical Command in 1986. The USNS Comfort, stationed at Naval Station Newport News, Va., is preparing to travel to New York City for a similar mission, where Gov. Andrew Cuomo said last week the height of the COVID-19 outbreak is expected to occur in about 45 days.
![]() ![]() Pharma chiefs expect coronavirus vaccine in 12-18 months Geneva, Switzerland (AFP) Mar 23, 2020 The pharmaceutical industry expects it will take 12 to 18 months to roll out a coronavirus vaccine, executives said Thursday, as they jointly pledged to make it available worldwide based on need. Bureaucracy could be slashed to speed up the process - but the time needed for safety testing could not be compromised, industry chiefs and the International Federation of Pharmaceutical Manufacturers and Associations told a virtual press conference hosted in Geneva. "We're confident technology will ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |